Skip to main content
Novartis AG logo

Novartis AG — Investor Relations & Filings

Ticker · NOVN ISIN · CH0038459415 LEI · 5493007HIVTX6SY6XD66 SW Manufacturing
Open in API
Filings indexed 1,070 across all filing types
Latest filing 2013-02-19 Regulatory Filings
Country CH Switzerland
Listing SW NOVN

About Novartis AG

https://www.novartis.com/

Novartis AG is a global medicines company focused on the research, development, manufacturing, and marketing of innovative healthcare products. The company's mission is to reimagine medicine to improve and extend people's lives. By leveraging advanced science and technology, Novartis develops a portfolio of treatments across various therapeutic areas to address the evolving needs of patients and societies. The firm is committed to delivering high-value medicines that tackle some of the most challenging healthcare issues worldwide.

Recent filings

Filing Released Lang Actions
MEDIA RELEASE
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filing by Novartis AG, which is a report of a foreign private issuer pursuant to the Securities Exchange Act of 1934. The content is a media release announcing the cancellation of a non-compete agreement and related compensation for a board member, Dr. Daniel Vasella. It does not contain financial statements, detailed financial data, or management discussion of financial results. It is primarily an announcement of a corporate governance decision and related compensation matter. The document length is 8330 characters, which is sufficient to contain substantive information, but the content is clearly a press release-type announcement rather than a financial report or detailed management report. It is not an earnings release, annual report, or interim report. It is not a regulatory certification or officer attestation. It is not a proxy solicitation or voting results announcement. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit into more specific categories such as Board/Management Information (MANG) since it is about compensation agreement cancellation rather than board changes, nor is it a Remuneration Information (DEF 14A) which typically details executive compensation plans or proxy statements. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2013-02-19 English
MEDIA RELEASE
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filing by Novartis AG, which is a report of a foreign private issuer pursuant to the Securities Exchange Act of 1934. The content is a media release announcing FDA approval of a drug (Zortress) for liver transplant patients, including study details and background information. There are no financial statements, quarterly or annual results, or detailed financial analysis present. The document is a regulatory announcement of a corporate event (drug approval) rather than a financial report or earnings release. It is not a report publication announcement since it contains substantive information rather than just a notice of report availability. The document fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2013-02-19 English
SC 13G/A
Major Shareholding Notification
2013-02-11 English
IRANNOTICE
Regulatory Filings Classification · 95% confidence The document is a short notice letter addressed to the US Securities and Exchange Commission referencing a disclosure made pursuant to the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act. It states that the disclosure was made in the Annual Report on Form 20-F for the year ended December 31, 2012, which was filed on January 23, 2013. The document itself does not contain the annual report or substantive financial data but is a notification about the filing of that report. The document length is only 1125 characters, indicating it is a brief notice rather than a full report. According to the MENU VS MEAL RULE, this is an announcement of a report filing, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for such notices and compliance documents.
2013-01-23 English
20-F
Annual Report FY 2012
2013-01-23 English
6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by Novartis AG, which is a report of a foreign private issuer pursuant to the Securities Exchange Act of 1934. It references exhibits including a Financial Report for Q4 2012 and an Interim Financial Report. The document length is only 1497 characters, which is quite short and does not contain the actual financial data or detailed report content but rather serves as a cover or notification of the attached reports. According to the 'Menu vs Meal' rule, such a short document that states reports are attached or referenced should be classified as a Regulatory Filing (RNS) rather than the actual financial report types like IR or 10-K. Therefore, the appropriate classification is Regulatory Filings (RNS).
2013-01-23 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.